- Exchange: SIX Swiss Ex
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Actelion Ltd+ Add to Watchlist
ATLN:VX125.700 CHF 1.700 1.37%
As of 05:12:19 ET on 05/04/2015.
Company Profile for Actelion Ltd (ATLN)
Actelion Ltd is a biopharmaceutical company focused on the discovery, development and commercialization of drugs for diseases with significant unmet medical needs. The Company focuses in the field of pulmonary arterial hypertension (PAH) with treatments for diseases from WHO Functional Class (FC) II through to FC IV, with oral, inhaled and intravenous medications.
Key Executives for Actelion Ltd (ATLN)
|Jean-Paul ClozelCEO/Co-Founder||Andre C MullerExec VP/CFO|
|Otto SchwarzExec VP/COO||Nicholas FrancoExec VP/Chief Bus Dev Officer|
|Guy BraunsteinExec VP/Head:Clinical Dev||Martine ClozelSenior VP/Chief Scientific Ofcr|
|Marian BorovskySenior VP/Secy/General Counsel||Christian AlbrichSenior VP/Head:Human Resources|
|Andrew C WeissSenior VP/Head:Investor Relations|